3
Publications
59
Citations
3
H-Index
2022
Active since
Affiliations
Robyn Du is an author at The University of Texas MD Anderson Cancer Center.
Publications per year
2022–2023
3
3
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC
Kaiwen Wang, Robyn Du, Nathaniel J. Myall et al. · Journal of Thoracic Oncology · 2023 · 20 citations · Full text
Rows per page
1–3 of 3